ORAL SOLID DOSE
Challenges With Pediatric Flavors For Taste Enhancement And Modulation
Taste masking for children can present unique challenges for drug developers. Learn how we can use flavor, not just to provide a desired taste, but also to provide taste masking.
The Future Of Oral Solid Dose Development And Innovation
Tom Sellig, CEO of Adare, discusses the ongoing relevance of small molecules, oral solid dose development, trends like GLP-1, and innovations like 3D printing in pharmaceuticals.
Taste Masking And Customized Release Technologies For OSD Forms
Watch to explore taste-masking solutions that can elevate your oral dosage forms, drive the success of your business, and address the needs of multiple, large patient populations.
Improve The Performance Of Your Small And Large Molecule Medicines
Explore the latest in nanotechnology advancements including recent clinical data, formulation applications, and API optimization to NanoImprove formulations.
Advances In Oral GLP-1 Analogs For Obesity
Discover how these groundbreaking Oral GLP-1 Analogs therapies are reshaping obesity management and addressing key challenges in formulation and delivery.
Improving Bioavailability, Drug Loads, And Pill Burdens Of Solid Dispersions
Explore the pros and cons of marketed amorphous solid dispersions with so-far unpublished data as well as a green alternative to ASDs: best-in-class nanotechnology to manufacture nanocrystals.
The Fusion-Based, Solvent-Free Process Disrupting Spray Drying
Review a commercially-ready process capable of reproducing spray-dried dispersions with less manufacturing complexity and environmental impact, and out-designing and outperforming spray drying.
Solvent-Free, Fusion-Based Amorphic Dispersion Process
Discover a solvent-free, fusion-based process that leverages frictional and shear forces to rapidly convert crystalline drugs and polymers into amorphous solid dispersions (ASDs).
Oral Solid Dosage Products: Water Activity And Primary Packaging Selection
Every individual oral solid dosage (OSD) product has different water activity initially and over time. Learn about USP <922> water activity and primary packaging selection of OSD products.
Virtual Tour Of A CDMO Facility In Vandalia, OH
Take a virtual tour of a CDMO facility in Vandalia, Ohio, that serves as a global R&D and commercial manufacturing center of excellence. The facility is just one of the seven state-of-the-art sites in the global network.
Oral Solid Dosage Technology
Discover how Parvulet's unique formulation simplifies medication administration for patients of all ages, especially those with swallowing difficulties.
Future Of Pharma Packaging: Trends, Tech, And Patient Solutions
Explore how traditional and innovative pharmaceutical packaging formats improve patient adherence, support emerging therapies, and shape the future of drug delivery and treatment outcomes.
Innovative Microencapsulation Technology
Discover how microencapsulation by coacervation can transform your formulations, ensuring smooth mouthfeel, effective taste masking, and customized release profiles.
Minitabs Technology
Discover a multiparticulate system that provides unparalleled flexibility in dosage forms, which allows you to create customized release profiles, precise dosing, and a wide range of delivery options.
Scaling Up A Revolutionary Amorphous Solid Dispersion Platform
Process parameter and quality attribute relationships, including those for typical pre- and post-ASD unit operations, will be explored in the context of real-world examples.
OSD Manufacturing For Pediatrics And Other Special Patient Populations
Watch to hear Steven Facer, Adare's Vice President of Business Development EU/ROW, discuss the challenges of pediatric oral solid dose manufacturing and how to overcome them.
The Future Of Blister Packaging
Maximize your productivity and efficiency with a versatile solution for inline cartoning, bundling, case packing, and pallet loading that also includes thermo and cold forming options to accommodate diverse packaging needs.
Improve The Bioavailability Of Poorly Soluble Drugs
KinetiSol is a fusion-based, solvent-free process that utilizes frictional and shear energies — in a fraction of the time of other amorphous solid dispersion technologies.
Taste Masking 101: Sensory And Performance Evaluation
Learn how techniques and innovations in taste masking sensory and performance evaluation can help accelerate your formulation development and confirm desired taste profile.
Nanoparticle Enabled Formulation And Drug Delivery Solutions
Discover how revolutionary and environmentally sustainable nanoparticle technologies coupled with innovative formulation approaches can address drug solubility issues and add value for patients.
Taste Masking 101: Applications And Technologies
Learn about key product parameters affecting patient acceptability and therapy adherence and taste masking strategies, including organoleptic and barrier coating approaches and microencapsulation technologies.
AdvaTab Orally Disintegrating Tablet Technology
Discover AdvaTab's innovative ODT technology, providing a convenient and easy-to-take dosage solution for patients of all ages.
Optimizing Pediatric Product Development For Commercialization Success
Ensuring medication adherence in pediatric patients presents challenges for pharmacotherapy. Explore various dosing solutions and learn how to streamline your pediatric development journey.
Patient- And Planet-Centric Bioavailability And Sustained Delivery
By reducing the size of drug particles, nanoforming offers new opportunities — from increased bioavailability to sustained drug delivery. Discover the potential benefits supported by case studies.
Pharmaceutical Outsourcing
Discover how Adare's innovative technologies, global reach, and commitment to quality and patient centricity can deliver exceptional solutions for your oral solid dose needs.
Technology To Overcome Absorption Hurdles And Solubility Limitations
For poorly soluble drugs, overcoming absorption hurdles can hinder development. Explore a solution that empowers researchers to overcome solubility limitations and accelerate drug development.
Water Activity Is A Critical Parameter For Microbial Stability
Learn about USP <1112> Application of Water Activity Determination to Non-sterile Pharmaceutical Products and USP <922> Water Activity, and why water activity is a critical parameter for microbial stability.
Formulation Of Crystalline Nanoparticles Enabling Superior Drug Load
Explore how bioavailability of poorly soluble APIs can be improved and patient compliance enhanced by reducing the size or number of tablets that a patient must take to achieve the required dose.
Diffucaps Technology
Discover how Diffucaps technology offers precise drug release, tailored dosage, and enhanced solubility, while minimizing irritation.
Taste Masking 101: Optimize Taste And Improve Patient Outcomes
Learn how swallowability and palatability play key factors related to patient acceptability and product development and about the variety of taste masking strategies including excipients, organoleptic and barrier coating approaches, and microencapsulation technologies.
